Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029499 | SCV000052150 | uncertain | Cystic fibrosis | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Uncertain significance. |
Labcorp Genetics |
RCV000029499 | SCV000284999 | benign | Cystic fibrosis | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000244736 | SCV000304483 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000759758 | SCV000603043 | benign | not provided | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000244736 | SCV000700535 | benign | not specified | 2016-11-29 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759758 | SCV000889295 | benign | not provided | 2022-09-19 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000029499 | SCV001137483 | likely benign | Cystic fibrosis | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001158764 | SCV001320419 | uncertain significance | CFTR-related disorder | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Johns Hopkins Genomics, |
RCV000029499 | SCV001711953 | benign | Cystic fibrosis | 2021-05-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000759758 | SCV001793092 | likely benign | not provided | 2019-08-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19017867, 20100616, 16251901, 16128988, 27264265, 9521595, 24272871, 9272157, 29174009, 25900089, 29807875, 28408918, 26500004, 28040058, 28546993, 27884173, 10875853, 15070876) |
Genome- |
RCV000029499 | SCV001822112 | likely benign | Cystic fibrosis | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257362 | SCV002529698 | likely benign | Hereditary pancreatitis | 2021-04-04 | criteria provided, single submitter | curation | |
Institute of Human Genetics, |
RCV000029499 | SCV002574059 | uncertain significance | Cystic fibrosis | 2022-09-05 | criteria provided, single submitter | curation | This variant was identified in 1 patient with a clinically confirmed diagnosis of cystic fibrosis. The variant was classified in the context of a project re-classifying variants in the German Cystic Fibrosis Registry (Muko.e.V.). Link: https://www.muko.info/angebote/qualitaetsmanagement/register/cf-einrichtungen/mukoweb. Criteria applied: PM3, PP4, BS2 |
Ambry Genetics | RCV000029499 | SCV002740787 | benign | Cystic fibrosis | 2014-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000759758 | SCV003917553 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | CFTR: BS2 |